Philips convenes 2026 AGM, shares in focus on AEX listing

By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-29, 09:50.

Philips (NL0000009538) has convened its 2026 Annual General Meeting of Shareholders in Amsterdam, with the agenda published including a proposal to re-appoint CEO Roy Jakobs, according to the company’s March 23 announcement. The AEX-listed health technology group trades under ticker PHIA on Euronext Amsterdam as a major European peer to Siemens Healthineers and GE HealthCare. Philips AGM 2026 investor information

AGM agenda and leadership proposal

The Philips AGM is scheduled for Friday, May 8, 2026, at Hotel Okura Amsterdam, with a start time of 10:00 CET per the AGM convening notice. The agenda includes the proposal to re-appoint Roy Jakobs, born 1974, as President and CEO and Chairman and member of the Board of Management, effective as of May 8, 2026. Report on Philips convening the 2026 AGM

The convening release also sets out other standard AGM items, including approval of the annual accounts and dividend, as well as authorization of the Board for share repurchases and issuance, which are typical governance points for a large-cap AEX constituent. Philips confirms contact details for Global External Relations and Investor Relations in Amsterdam, underlining its continued engagement with institutional and retail investors. Philips investor relations overview

Weekday focus on operations and strategy

Philips positions itself as a global health technology leader, with operations centered on diagnostics, image-guided therapy, connected care and personal health, and the AGM agenda reflects this operational focus through its strategy and governance proposals. The company continues to execute on portfolio simplification and patient safety initiatives following earlier legacy issues, while emphasizing growth in connected care and hospital informatics relative to peers like Siemens Healthineers and GE HealthCare in Europe and the United States. Philips company profile and strategy

Analyst valuation tools such as TradingKey assign Koninklijke Philips NV a current valuation score of 8.72, ranking 67 out of 203 within the Healthcare Equipment & Supplies industry, which situates Philips in the mid-range of its sector on that metric while maintaining its role as a core Dutch health technology name on the AEX. Koninklijke Philips NV valuation score

The product behind the Philips stock

Philips generates a substantial portion of its revenue from medical imaging systems such as MRI and CT scanners, which support hospital diagnostics worldwide. These systems are complemented by related software and services, positioned alongside competitors like Siemens Healthineers and GE HealthCare in the global imaging market.

Where the Philips shares trade today

The Philips shares (NL0000009538) trade on Euronext Amsterdam under ticker PHIA, with recent prices quoted in euros on the AEX; the latest verified price is sourced from the Euronext Amsterdam listing during regular European trading hours.

This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell any security, or a solicitation of any transaction. All data are based on sources believed to be reliable but cannot be guaranteed; investors should conduct their own research or consult a qualified advisor before making investment decisions.